Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
The constantly growing contribution of depressive disorders to the global disease statistics calls for a growth of treatment effectiveness and optimization. Antidepressants are the most frequently prescribed medicines for depressive disorders. However, development of a standardized pharmacotherapeut...
Enregistré dans:
| Auteurs principaux: | L. K. Khokhlov, N. E. Lukyanov |
|---|---|
| Format: | article |
| Langue: | RU |
| Publié: |
Scientific Сentre for Family Health and Human Reproduction Problems
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/ef2a9816e819456a8e250423b72feaf5 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program
par: Michelle Liu, et autres
Publié: (2021) -
Pharmacogenetics
Publié: (1991) -
Effect of Pharmacogenetic-Based Decision Support Tools in Improving Depression Outcomes: A Systematic Review
par: Aboelbaha S, et autres
Publié: (2021) -
Mind your state: Insights into antidepressant nonadherence
par: De Wet Wolmarans, et autres
Publié: (2016) -
Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
par: Xandra García-González, et autres
Publié: (2021)